Search » prep
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
The form used to apply for pharmaceutical company cost support has been replaced by a series of three drug-specific tools for: HIV prevention (PrEP and nPEP), HIV treatment, and hepatitis (A and B).News Article updated on 04/10/2023
-
Recap: 17th Ryan White HIV/AIDS Program Clinical Care Conference
Highlights from the 2017 Ryan White Clinical Conference by Dr. Laura Cheever.
Blog updated 01/13/2023
-
HRSA at USCA 2016
At USCA 2016, HRSA staff presented a Pathway track and participated in a handful of Secretary's Minority AIDS Initiative Fund (SMAIF) Pathway sessions with their HHS colleagues.
Blog updated 06/01/2021
-
Long-Acting Injectable ART: Coverage and Cost-Sharing Considerations
Review of fact sheet on different coverage and cost-sharing considerations for LAI ART across public and private payers.Blog updated 12/22/2022
-
HRSA Launches PLOS Special Collection Highlighting Ryan White HIV/AIDS Program’s Innovative Models of Care
Collection of manuscripts on HRSA’s RWHAP featuring use of data; services delivered and outcomes; implementation science; and other strategies.Blog updated 04/21/2021
-
HRSA Highlights for AIDS 2018
One of the primary objectives of AIDS 2018 is to explore evidence-informed HIV interventions designed for key populations.
Blog updated 09/25/2023
-
Creative Responses to COVID-19
In response to clinic operation curtailments during COVID-19 lockdowns, telehealth services have expanded across the nation.
Blog updated 01/17/2023